Month: April 2021

Nasdaq CopenhagenLondon Stock ExchangeOther stakeholders Date         12.04.2021 Share buy-back programme – week 14 The share buy-back programme runs from and including 4 February 2021 up to and including 30 July 2021. During this period Ringkjøbing Landbobank will buy-back shares to a maximum market value of DKK 255 million under a share buy-back programme, see company announcement of 3 February 2021. The programme is implemented in compliance with EU Commission Regulation No. 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No. 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” regulation. The following transactions have been made under the programme:Date Number of shares Average purchase price (DKK) Total purchased under the programme (DKK)Total in accordance with the last announcement   156,700  600.46  94,091,76805...

Nasdaq CopenhagenLondon Stock ExchangeØvrige interessenter Dato         12.04.2021 Aktietilbagekøbsprogram – uge 14 Aktietilbagekøbsprogrammet løber i perioden fra og med den 4. februar 2021 til og med den 30. juli 2021. I denne periode vil Ringkjøbing Landbobank tilbagekøbe aktier for en maksimal markedsværdi af 255 mio. kroner i et aktietilbagekøbsprogram, jf. selskabsmeddelelse af 3. februar 2021. Programmet gennemføres i henhold til EU-Kommissionens forordning nr. 596/2014 af 16. april 2014 og EU-Kommissionens delegerede forordning nr. 2016/1052 af 8. marts 2016, der tilsammen udgør ”Safe Harbour”-reguleringen. Følgende transaktioner er foretaget under programmet:Dato Antal aktier (stk.) Gennemsnitligkøbspris (kroner) Tilbagekøbt i altunder programmet (kroner)I alt i henhold til seneste meddelelse   156.700  600,46  94.091.76805....

Octopus Titan VCT plc 12 April 2021 Director Appointments Octopus Titan VCT plc (“the Company”) is delighted to announce the appointment of Lord Rockley as an independent non-executive Director with effect from 8 April 2021. The Company also announces the intention to appoint Gaenor Bagley as an independent non-executive Director subject to the approval by shareholders at the forthcoming Annual General Meeting of a resolution to amend the Company’s Articles of Association to increase the aggregate annual remuneration of directors to allow for her appointment. Lord Rockley Anthony is a qualified chartered accountant and former partner at KPMG. He joined KPMG in 1983 and held various positions throughout his career most notably within the banking sector and latterly as the lead audit partner in KPMG’s Private Equity Group (‘PEG’) which...

PREPARATORY INFORMATION AND DOCUMENTS FOR THE COMBINED SHAREHOLDERS’ MEETING OF 19 MAY 2021Paris, France, Friday 12 April 2021  Nexity’s shareholders are informed that the Combined Shareholders’ Meeting (ordinary and extraordinary) will be held on Wednesday 19 May 2021 at 10:00 am at the company headquarter, 19 rue de Vienne – TSA 50029 – 75801 PARIS Cedex 08. In the context of Covid-19 and taking into account the ordinance No. 2020-321 of 25 March 2020 as amended by Ordinance no. 2020-1497 of 2 December 2020, the provisions of which were extended until 31 July 2021 by Decree no. 2021-255 of 9 March 2021 (in particular Article 4 of this Ordinance), Nexity’s Board of directors decided, on 30 March 2021, to exceptionally hold the shareholders’ meeting  behind closed doors, without the shareholders and other persons entitled...

Company announcement no. 12 2020/2021Allerød, 12 April 2021 Matas acquires health tech platform and enters into collaboration with online pharmacy   As part of the development of its subsidiary Firtal Group, Matas has via Web Sundhed Aps acquired two IT and sourcing companies, at a price of DKK 65.6 million plus contingent consideration of up to DKK 20 million. Web Sundhed Aps will going forward provide IT systems, logistics and purchasing services to Gazelle Online Apotek, which operates webapoteket.dk Established by married couple Trine and Lars Persson in 2011, webapoteket.dk, which is currently operated by Trine Persson through Gazelle Online Apotek, is the most widely used online pharmacy in Denmark, according to the 2020 e-commerce analysis of Dansk Erhverv Digital Handel. Trine Persson, a pharmacist and the holder of the chemist’s...

Selskabsmeddelelse nr. 12 2020/21Allerød, 12. april 2021 Matas har købt healthtech-platform og indgår samarbejde med onlineapotek Som led i udviklingen af sit datterselskab Firtal Group har Matas via Web Sundhed Aps købt to IT-og indkøbsselskaber for DKK 65,6 mio. plus yderligere betingede vederlag på op til i alt DKK 20 mio. Aftalen betyder, at Web Sundhed Aps fremover vil levere IT-systemer, logistik- og indkøbsydelser til Gazelle Online Apotek, der driver webapoteket.dk. Webapoteket.dk er stiftet af ægteparret Trine og Lars Persson i 2011, og onlineapoteket, der i dag drives af Trine Persson gennem Gazelle Online Apotek, er det mest benyttede onlineapotek i Danmark, iflg. E-handelsanalysen 2020 fra Dansk Erhverv Digital Handel. Gazelle Online Apotek vil fortsat være 100% ejet af apoteker Trine Persson, som har apotekerbevillingen,...

MODALITES DE MISE A DISPOSITION OU DE CONSULTATION DES DOCUMENTS PREPARATOIRES A L’ASSEMBLEE GENERALE MIXTE DU 19 MAI 2021Paris, le 12 avril 2021  Les actionnaires de la société Nexity (la Société) sont informés qu’une Assemblée Générale Mixte (assemblée extraordinaire et ordinaire), est convoquée pour se tenir le mercredi 19 mai 2021 à 10 heures au siège social de la Société, 19 rue de Vienne – TSA 50029 – 75801 PARIS Cedex 08. Dans le contexte sanitaire actuel d’épidémie de covid-19, et conformément à l’ordonnance n° 2020-321 du 25 mars 2020, telle que modifiée par l’ordonnance n° 2020-1497 du 2 décembre 2020, et dont les dispositions ont été prorogées jusqu’au 31 juillet 2021 par le décret n° 2021-255 du 9 mars 2021 (en particulier l’article 4 de cette ordonnance), le Conseil d’administration de la Société a décidé, le...

HOUSTON, April 12, 2021 (GLOBE NEWSWIRE) — VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) (“VAALCO” or the “Company”) today announced that its Board of Directors has named George Maxwell as Chief Executive Officer effective April 12, 2021. Mr. Maxwell, who has been a Non-Executive Director of the Company since June 2020 and resides in the U.K., will continue to serve as a member of the Board. Cary Bounds who has served as Chief Executive Officer since 2016 will leave VAALCO to pursue other interests. The Company also provided details on its newly updated forward strategy. The Company’s stated goal is to continue to be one of the leading independent exploration and production companies in West Africa, with a strategy of achieving significant shareholder returns by maximizing the value of, and free cash flow from, its existing resources,...

PRESS RELEASE April 12, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that, since December 2020 when its shareholdings in Scandion Oncology fell below 5%, Saniona has sold its remaining shares of Scandion Oncology A/S (Nasdaq First North Growth Market: SCOL) on the open market. As a result of these transactions, Saniona no longer holds any shares in Scandion Oncology.   Scandion Oncology was formed in 2017 through a spin-out of certain oncology assets from Saniona. At the time of the spin-out, Saniona owned a 51% stake in Scandion Oncology. Since then, Scandion has advanced into Phase II clinical trials with lead candidate SCO-101 for drug resistant metastatic colorectal cancer and has advanced the listing of its shares from the Spotlight Stock Market onto the Nasdaq First...

PRESSMEDDELANDE 12 april 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att man sedan december 2020, när aktieinnehavet i Scandion Oncology sjönk under 5 procent, har sålt den återstående delen av sitt innehav i Scandion Oncology A/S (Nasdaq First North Growth Market: SCOL) i ordinarie börshandel. Efter dessa transaktioner äger Saniona inte längre några aktier i Scandion Oncology.   Scandion Oncology bildades 2017 genom en avknoppning av vissa tillgångar inom onkologi från Saniona. Vid tiden för avknoppningen innehade Saniona en ägarandel om 51 procent i Scandion Oncology. Sedan dess har Scandion avancerat läkemedelskandidaten SCO-101 för läkemedelsresistent metastaserad kolorektal cancer till kliniska Fas 2-studier och bytt handelsplats för bolagets aktie...